Resmed (RMD) Research & Development (2009 - 2026)
Resmed's (RMD) quarterly Research & Development came in at $94.3 million in Q1 2026, up 12.3% YoY from $83.9 million in Q1 2025, and up 3.63% on a QoQ basis from $91.0 million in Q4 2025.
Resmed (RMD) Research & Development (2009 - 2026) Analysis & Trends
Resmed (RMD) has 18 years of Research & Development data on file, last reported at $94.3 million in Q1 2026.
- Quarterly Research & Development rose 12.3% year-over-year to $94.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $359.0 million (up 10.22% YoY) and the FY2025 annual result came in at $331.3 million, up 7.73% from the prior year.
- Research & Development advanced to $94.3 million in Q1 2026, from $91.0 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $94.3 million in Q1 2026 to a low of $63.2 million in Q3 2022.
- A 5-year average of $78.2 million and a median of $78.1 million in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2023 — Research & Development increased 21.5% — and 2024, when it gained 0.83%.
- Tracing RMD's Research & Development over 5 years: stood at $69.9 million in 2022, then gained by 5.73% to $73.9 million in 2023, then climbed by 10.14% to $81.4 million in 2024, then climbed by 11.79% to $91.0 million in 2025, then increased by 3.63% to $94.3 million in 2026.
- The last three Research & Development figures came in at $94.3 million (Q1 2026), $91.0 million (Q4 2025), and $87.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Align Technology | 11.37 Bn | 10.27 Bn | 757.43 Mn | 102.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 105.73 Mn |
| Mar 31, 2026 | 94.27 Mn |
| Dec 31, 2025 | 90.97 Mn |
| Sep 30, 2025 | 87.32 Mn |
| Jun 30, 2025 | 86.44 Mn |
| Mar 31, 2025 | 83.94 Mn |
| Dec 31, 2024 | 81.37 Mn |
| Sep 30, 2024 | 79.52 Mn |
| Jun 30, 2024 | 80.86 Mn |
| Mar 31, 2024 | 77.07 Mn |
| Dec 31, 2023 | 73.88 Mn |
| Sep 30, 2023 | 75.71 Mn |
| Jun 30, 2023 | 78.14 Mn |
| Mar 31, 2023 | 76.44 Mn |
| Dec 31, 2022 | 69.87 Mn |
| Sep 30, 2022 | 63.19 Mn |
| Jun 30, 2022 | 64.32 Mn |
| Mar 31, 2022 | 66.80 Mn |
| Dec 31, 2021 | 62.51 Mn |
| Sep 30, 2021 | 59.95 Mn |